Study of Effectiveness of Mexyn-A

Evangelical Synod Medical Centre

Status

Completed

Conditions

Pruritus

Treatments

Device: Mexyn-A

Study type

Interventional

Funder types

Other

Identifiers

NCT00568204

EvangelicalSynodMC

Details and patient eligibility

About

Atomised Methoxymethane-in-Aqua (MEXYN-A) a new topical self-chilled, non-steroidal, non-flammable, pressurised spray which embodies in one simultaneous application, most of the currently recognised and effective chemical, mechanical and thermal anti-pruritic therapies and hydrotherapy.

Full description

The primary clinical endpoint was to establish MEXYN-A efficacy and safety in abolishing or reducing pruritus related to cutaneous diseases, insect bites and poison ivy, within few seconds of the application. The secondary endpoint was to measure the itch free period as a result of the new intervention.

Enrollment

279 patients

Sex

All

Ages

5 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients suffering from severe itching due to : Atopic Dermatitis, contact dermatitis, psoriasis, urticaria, xerosis, prickly heat, genital pruritus, chicken pox, aquagenic pruritus, lichen planus, poison ivey, insect bites.
Past experience with the use of at least one conventional medication for pruritus or conventional medication for the same disorder patients suffered.

Exclusion criteria

Patients who have taken any anti-pruritic drug during the month prior to participation.
Patients who have taken drugs for any reason for 2 days prior to participating in the study.